- Home
- TTOO vs ALVR Comparison
TTOO vs ALVR Comparison
Compare TTOO & ALVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTOO
- ALVR
- Stock Information
- Founded
- TTOO 2006
- ALVR 2013
- Country
- TTOO United States
- ALVR United States
- Employees
- TTOO N/A
- ALVR N/A
- Industry
- TTOO Medical/Dental Instruments
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TTOO Health Care
- ALVR Health Care
- Exchange
- TTOO Nasdaq
- ALVR Nasdaq
- Market Cap
- TTOO 36.4M
- ALVR 87.7M
- IPO Year
- TTOO 2014
- ALVR 2020
- Fundamental
- Price
- TTOO $0.97
- ALVR $0.90
- Analyst Decision
- TTOO Hold
- ALVR Sell
- Analyst Count
- TTOO 1
- ALVR 5
- Target Price
- TTOO $5.00
- ALVR $1.00
- AVG Volume (30 Days)
- TTOO 710.5K
- ALVR 155.6K
- Earning Date
- TTOO 11-13-2024
- ALVR 11-04-2024
- Dividend Yield
- TTOO N/A
- ALVR N/A
- EPS Growth
- TTOO N/A
- ALVR N/A
- EPS
- TTOO N/A
- ALVR N/A
- Revenue
- TTOO $7,164,000.00
- ALVR N/A
- Revenue This Year
- TTOO $50.31
- ALVR N/A
- Revenue Next Year
- TTOO $117.92
- ALVR N/A
- P/E Ratio
- TTOO N/A
- ALVR N/A
- Revenue Growth
- TTOO N/A
- ALVR N/A
- 52 Week Low
- TTOO $0.90
- ALVR $0.58
- 52 Week High
- TTOO $8.38
- ALVR $2.49
- Technical
- Relative Strength Index (RSI)
- TTOO 18.34
- ALVR 69.10
- Support Level
- TTOO $0.90
- ALVR $0.74
- Resistance Level
- TTOO $1.86
- ALVR $0.91
- Average True Range (ATR)
- TTOO 0.15
- ALVR 0.06
- MACD
- TTOO -0.00
- ALVR 0.01
- Stochastic Oscillator
- TTOO 5.72
- ALVR 94.50
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.